Related Experiment Video
Updated: Aug 11, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
Clonal diseases of large granular lymphocytes
1Veterans Administration Hospital, Syracuse, NY 13210.
Large granular lymphocytes (LGLs) can cause distinct clinical syndromes. While T-LGL leukemia involves clonal CD3+ LGLs, most CD3- LGL increases show polyclonal lymphocytosis and a chronic course, requiring further study for clonal progression.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Large granular lymphocytes (LGLs) are involved in various hematologic and immunologic conditions.
- Increased LGL counts can manifest as distinct clinical syndromes, including T-cell large granular lymphocyte (T-LGL) leukemia and natural killer (NK)-LGL leukemia.
- Understanding the nature of LGL proliferation is crucial for diagnosis and management.
Purpose of the Study:
- To differentiate between distinct clinical syndromes associated with increased circulating LGLs.
- To characterize the immunophenotypic and clinical features of T-LGL leukemia and NK-LGL leukemia.
- To investigate the underlying mechanism of LGL lymphocytosis in patients without overt NK-LGL leukemia.
Main Methods:
- Analysis of clinical presentations and immunophenotypic characteristics (CD3+, CD3-) of circulating LGLs.
- Distinguishing between clonal and polyclonal LGL lymphocytosis using genetic analyses (X-linked gene analyses).
- Correlating LGL proliferation patterns with clinical syndromes and disease course.
Main Results:
- T-LGL leukemia is characterized by clonal CD3+ LGL proliferation, often presenting with chronic neutropenia and autoimmune features.
- NK-LGL leukemia involves clonal CD3- LGL proliferation, typically presenting acutely with hepatosplenomegaly and systemic illness.
- Most patients with increased CD3- LGLs exhibit polyclonal lymphocytosis and a chronic clinical course, without features of NK-LGL leukemia.
Conclusions:
- Circulating LGL increases encompass at least three distinct clinical syndromes.
- While T-LGL and NK-LGL leukemias involve clonal CD3+ and CD3- LGL proliferations respectively, a significant subset of CD3- LGL increases represents polyclonal lymphocytosis with a chronic course.
- Further research is necessary to ascertain the potential for clonal progression in patients with polyclonal LGL lymphocytosis.
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cytomegalovirus Disease

